2025 Annual Meeting | N2 - Neuroscience in the Clinic: Regenerative Rehabilitation
Program Materials Program Evaluations
03:30 PM - 03:35 PM PDT | Speaker |
Neural Recovery Case Presentation
Matine Azadian |
03:35 PM - 03:55 PM PDT | Speaker |
Regenerative Rehabilitation
Fabrisia Ambrosio, PhD |
03:55 PM - 04:15 PM PDT | Speaker |
Therapeutics for Stroke Recovery
Sean I. Savitz, MD |
04:15 PM - 04:35 PM PDT | Speaker |
Neural Interfaces for Recovery after Spinal Cord Injury
Robert Gaunt, PhD |
04:35 PM - 04:45 PM PDT | Abstract |
002 - Stem Cell-Derived Spinal Cord Organoid Model: Temporal and Cell-Specific Analysis of Molecular Effects of a Risdiplam Analogue
Stefania Corti, MD, PhD |
04:45 PM - 05:05 PM PDT | Speaker |
Creating the Optimal Environment for Neural Recovery
Paul M. George, MD, PhD, MSE, FAAN |
05:05 PM - 05:30 PM PDT | Q&A |
Q&A Panel
Paul M. George, MD, PhD, MSE, FAAN, Fabrisia Ambrosio, PhD, Robert Gaunt, PhD, Sean I. Savitz, MD, Matine Azadian |
Paul M. George, MD, PhD, MSE, FAAN | Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. Dr. George has received intellectual property interests from a discovery or technology relating to health care. Dr. George has received personal compensation in the range of $5,000-$9,999 for serving as a Adjudicator with Baim Insititute. Dr. George has a non-compensated relationship as a Board Member with 好色先生 that is relevant to AAN interests or activities. |
Fabrisia Ambrosio, PhD | Fabrisia Ambrosio, PhD has nothing to disclose. |
Robert Gaunt, PhD | Dr. Gaunt has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Blackrock Neurotech. The institution of Dr. Gaunt has received research support from Blackrock Neurotech. The institution of Dr. Gaunt has received research support from NIH. The institution of Dr. Gaunt has received research support from Craig H. Neilsen Foundation. Dr. Gaunt has received intellectual property interests from a discovery or technology relating to health care. Dr. Gaunt has a non-compensated relationship as a Scientific Advisory Board Member with Neurowired that is relevant to AAN interests or activities. |
Stefania Corti, MD, PhD | Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. |
Francesca Beatrice | Francesca Beatrice has nothing to disclose. |
Chiara Cordiglieri, PhD | Dr. Cordiglieri has nothing to disclose. |
Matteo Miotto | Matteo Miotto has nothing to disclose. |
Simona Lodato | No disclosure on file |
Federica Rizzo, MD | No disclosure on file |
Giacomo Comi | Giacomo Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Giacomo Comi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. |
Linda Ottoboni | Linda Ottoboni has nothing to disclose. |
Megi Meneri, MD, PhD | Dr. Meneri has nothing to disclose. |
Delia Gagliardi, MD, PhD | Dr. Gagliardi has nothing to disclose. |
Andrea D'Angelo | No disclosure on file |
Jung Keun Hyun, MD, PhD | Prof. Hyun has nothing to disclose. |
Lina Liu | Ms. Liu has nothing to disclose. |
Jun Hee Lee, PhD | Prof. Lee has nothing to disclose. |
Sean I. Savitz, MD | Dr. Savitz has nothing to disclose. |
Matine Azadian | Dr. Azadian has nothing to disclose. |